GN Store Nord A/S
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000BR6V48
GN
GN Store Nord A/S
GICS: 25201010
·
Sector: Health Care
·
Sub-Sector: Health Care
NAME
GN Store Nord A/S
ISIN
DK0010272632
TICKER
GN
MIC
XCSE
REUTERS
GN.CO
BLOOMBERG
GN DC
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
In this section you will find transaction histories for short sales.
ai
NALIZER
Short sellers are obliged to report when building up positions from 0.50% and when reducing positions up to 0.50%. If there are open positions >= 0.50% in the reporting registers, these are shown in the following overview.
Fourteen Short sale positions >= 0.50% are currently registered as reportable-relevant
| Date | Position Holder | Position | # | Action |
|---|---|---|---|---|
| 14.11.2024 | AQR Capital Management, LLC | 0,81% | 6 | |
| 13.11.2024 | Gladstone Capital Management LLP | 0,81% | 15 | |
| 13.11.2024 | Kintbury Capital LLP | 0,66% | 11 | |
| 07.11.2024 | AKO Capital LLP | 1,04% | 73 | |
| 01.11.2024 | Pertento Partners LLP | 0,90% | 5 | |
| 22.10.2024 | Balyasny Asset Management (UK) LLP | 0,52% | 11 | |
| 18.10.2024 | PSquared Asset Management AG | 0,70% | 3 | |
| 16.10.2024 | Millennium International Management LP | 0,50% | 32 | |
| 14.10.2024 | ELEVA Capital SAS | 0,64% | 2 | |
| 12.09.2024 | Square Circle IA LP | 0,50% | 1 | |
| 13.08.2024 | Marshall Wace LLP | 0,50% | 53 | |
| 27.05.2024 | Connor Clark & Lunn Investment Management Ltd | 0,50% | 1 | |
| 17.01.2024 | Qube Research & Technologies Ltd | 0,50% | 3 | |
| 25.10.2023 | Balyasny Europe Asset Management LLP | 0,53% | 8 |
The overview shows all positions and their last reported status. Please note that when reducing positions, falling below the 0.50% limit means that the mandatory reporting obligations no longer have to be applied. As a rule, it can be assumed that the positions have been completely reduced following a longer period of inactivity. Positions < 0.50% are therefore only of limited significance.
| Date | Position Holder | Position | # | Action |
|---|---|---|---|---|
| 14.11.2024 | AQR Capital Management, LLC | 0,81% | 6 | |
| 13.11.2024 | Gladstone Capital Management LLP | 0,81% | 15 | |
| 13.11.2024 | Kintbury Capital LLP | 0,66% | 11 | |
| 07.11.2024 | AKO Capital LLP | 1,04% | 73 | |
| 01.11.2024 | Pertento Partners LLP | 0,90% | 5 | |
| 22.10.2024 | Balyasny Asset Management (UK) LLP | 0,52% | 11 | |
| 18.10.2024 | PSquared Asset Management AG | 0,70% | 3 | |
| 16.10.2024 | Millennium International Management LP | 0,50% | 32 | |
| 14.10.2024 | ELEVA Capital SAS | 0,64% | 2 | |
| 12.09.2024 | Square Circle IA LP | 0,50% | 1 | |
| 13.08.2024 | Marshall Wace LLP | 0,50% | 53 | |
| 27.05.2024 | Connor Clark & Lunn Investment Management Ltd | 0,50% | 1 | |
| 17.01.2024 | Qube Research & Technologies Ltd | 0,50% | 3 | |
| 25.10.2023 | Balyasny Europe Asset Management LLP | 0,53% | 8 | |
| 17.03.2023 | Odey Asset Management LLP | 0,24% | 11 | |
| 01.02.2023 | Canadian Pension Plan Investment Board | 0,42% | 73 | |
| 14.10.2022 | Mirabella Financial Services LLP | 0,49% | 14 | |
| 13.03.2020 | Exane Asset Management | 0,49% | 59 | |
| 27.02.2019 | Partner Fund Management, L.P. | 0,36% | 2 | |
| 08.10.2018 | GLG Partners LP | 0,41% | 10 | |
| 13.01.2017 | GAM Investment Management (Switzerland) Ltd. | 0,49% | 2 | |
| 29.09.2016 | BDL Capital Management | 0,41% | 2 | |
| 26.09.2016 | Naya Capital Management UK Limited | 0,49% | 12 | |
| 07.09.2016 | Bodenholm Capital AB | 0,44% | 3 | |
| 04.08.2016 | Parvus Asset Management Europe Limited | 0,47% | 2 | |
| 08.06.2016 | Carve Capital AB | 0,48% | 6 | |
| 12.02.2016 | SFM UK Management LLP | 0,41% | 3 | |
| 07.01.2016 | UBS O`Connor Limited | 0,37% | 2 | |
| 30.10.2015 | OCH-ZIFF Management Europe Limited | 0,02% | 3 | |
| 13.10.2015 | JP Morgan Asset Management (UK) Limited | 0,49% | 3 | |
| 01.10.2015 | TT International | 0,39% | 2 | |
| 13.08.2015 | Naya Management LLP | 0,46% | 5 | |
| 06.02.2015 | WorldQuant LLC | 0,49% | 4 |
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.
